Treatment Pathways

A 10-year major osteoporotic fracture risk of at least 10% was defined as a positive risk assessment. People with osteopenia were modelled as receiving colecalciferol and calcium. People with normal bone mineral density were modelled as receiving no treatment. People diagnosed with osteoporosis were modelled as receiving alendronate plus colecalciferol and calcium. A 10-year hip fracture risk of at least 3% was defined as a positive risk assessment.